NSE ScannerMedical Devices & Supplies · Medical Specialties · NSE: GML · data 2026-11-01
Galaxy Medicare Limited
In plain words
Price: 24.4% below its 52-week high of ₹23.8.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹40 cr |
| Net profit (last 12 months) | ₹3 cr |
| Sales growth, 3 years (yearly) | 8.6% |
| Profit growth, 3 years (yearly) | 29.6% |
At a glance
P/E 6.9, P/B 0.7, dividend yield 3.9%. Price relative to earnings and book value (low is cheaper, not better).
ROE 10.6%, ROCE 11.9%, operating margin 9.2%: how much profit it earns on the money it uses.
Debt/equity 0.10, Profit growth 29.6% and sales growth 8.6% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Virtually debt-free (debt/equity 0.1 or less).
- Profit grew 29.6% a year over 3 years.
- Pays a dividend yielding 3.9%.
None flagged by these rules.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Smart-money activity
5/100 · Weak over the last ~60 sessions
- Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Common questions
Is Galaxy Medicare Limited debt-free?
Its latest reported debt-to-equity ratio is 0.1.
What is Galaxy Medicare Limited's P/E ratio?
About 6.9, based on the last 12 months' earnings and a price of ₹18 (data 2026-11-01).
What is the 52-week high and low of Galaxy Medicare Limited?
The 52-week high is ₹23.8 and the 52-week low is ₹15.15.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Galaxy Medicare Limited | ₹18 | ₹27 cr | 6.9 | 0.7 | 10.6% | 11.9% | 0.1 | -16.3% |
| Yash Optics and Lens Limited | ₹118.05 | ₹292 cr | 32.3 | 2.9 | 9.5% | 11.6% | 0.05 | -9.2% |
| Nureca Ltd. | ₹293.8 | ₹285 cr | 61.1 | 1.5 | 1.1% | 3.4% | 0.01 | +13.0% |
| Avience Biomedicals Limited | ₹253.15 | ₹139 cr | 11.7 | 3.3 | 32.4% | 35.9% | 0.92 | -35.9% |
| Mohini Health & Hygiene Ltd. | ₹26.95 | ₹49 cr | — | 0.6 | -17.2% | -9.4% | 0.41 | -41.0% |
| Gkb Ophthalmics Limited | ₹58.3 | ₹30 cr | 9.1 | — | 2.3% | 8.7% | 0.22 | -30.6% |
Compare GML with YASHOPTICS in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open GML in NSE Scanner →